Stephen Schuster, MD, Gives Advice for Treating Aggressive Lymphomas During COVID-19 Pandemic

Article

Stephen Schuster, MD, talked about the benefits of conducting routine visits remotely during the COVID-19 pandemic, allowing doctors to see and treat more patients safely and efficiently.

Stephen Schuster, MD, of Penn Medicine talked about the benefits of conducting routine visits remotely during the COVID-19 pandemic, allowing doctors to see and treat more patients safely and efficiently.

Transcription:

As I said, some of our visits that are very routine can be done remotely. That actually saves time, number 1, and it also reduces traffic to the cancer center and through the waiting room and into the exam room. I think if we can continue to maintain that, we’ll have greater capacity to see patients that need to be seen. People that are being evaluated up front with either a new diagnosis or for evaluation for CAR T, we’ll be able to bring more patients in because our schedule won’t be quite as cluttered with routine follows up, which we can still do, but we can do more efficiently and remotely. We’ll have more space in clinic, more space in our schedules, and probably be able to handle a greater volume of patients.

Recent Videos
Experts at Yale Cancer Center highlight ongoing trials intended to improve outcomes across mantle cell lymphoma, T-cell lymphoma, and other populations.
Yale’s COPPER Center aims to address disparities and out-of-pocket costs for patients, thereby improving the delivery of complex cancer treatment.
Non-Hodgkin lymphoma and other indolent forms of disease may require sequencing new treatments for years or decades, said Scott Huntington, MD, MPH, MSc.
Fixed-duration therapy may be more suitable for younger patients, while continuous therapy may benefit those who are older with more comorbidities.
A new clinical trial aims to offer a novel allogenic CAR T-cell product for patients with lymphoma closer to home.
Determining the molecular characteristics of one’s disease may influence the therapy employed in the first line as well as subsequent settings.
Related Content